Astellas Pharma | 4503 - Operating Profit


Astellas Pharma reported JPY48.57B in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Astellas Pharma JPY 48.57B 85.97B Mar/2026
Chugai Pharma JPY 158.77B 10.24B Mar/2026
Daiichi Sankyo JPY 89.54B 42.01B Dec/2025
Eisai JPY -10.31B 30.35B Mar/2026
Kyowa Hakko Kirin JPY 9.52B 28.83B Mar/2026
M3 JPY 10.65B 15.37B Mar/2026
Otsuka Holdings JPY 118.21B 50.97B Mar/2026
Shionogi JPY 17.99B 55.98B Mar/2026
Sumitomo Dainippon JPY -3.56B 79.22B Mar/2026
Takeda JPY -13.62B 182.44B Mar/2026
Terumo JPY 31.45B 12.43B Mar/2026